162 related articles for article (PubMed ID: 10823125)
1. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
Feinmesser M; Sulkes A; Morgenstern S; Sulkes J; Stern S; Okon E
J Clin Pathol; 2000 Apr; 53(4):286-91. PubMed ID: 10823125
[TBL] [Abstract][Full Text] [Related]
2. Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases.
Lazzaro B; Anderson AE; Kajdacsy-Balla A; Hessner MJ
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):234-41. PubMed ID: 11556751
[TBL] [Abstract][Full Text] [Related]
3. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
4. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
5. Gains and losses of HLA class II (DR) and CD4 in atypical hyperplasia, carcinoma in situ and infiltrating ductal carcinoma of the breast.
Tamiolakisl D; Venizelos I; Lambropoulou M; Jivannakis T; Seliniotakis E; Tsikouras P; Limberis V; Tsalkidis A; Papadopoulos N
Acta Medica (Hradec Kralove); 2004; 47(4):257-62. PubMed ID: 15844251
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
Lucin K; Iternicka Z; Jonjić N
Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
[TBL] [Abstract][Full Text] [Related]
7. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
Zuk JA; Walker RA
J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
[TBL] [Abstract][Full Text] [Related]
10. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
[TBL] [Abstract][Full Text] [Related]
11. The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast.
Reyes C; Nadji M
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):624-7. PubMed ID: 25710588
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
Oldford SA; Robb JD; Watson PH; Drover S
Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
[TBL] [Abstract][Full Text] [Related]
15. MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer.
Wolkersdörfer T; Füssel M; Kiesslich T; Neureiter D; Berr F; Aust D; Wolkersdörfer GW
Oncol Rep; 2011 Nov; 26(5):1165-71. PubMed ID: 21874254
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA-DR antigen and characterization of the lymphocytic infiltrate in normal mucosa, tubulo-villous adenoma and invasive carcinoma of the colon.
Tamiolakis D; Venizelos J; Papadopoulos N; Lambropoulou M; Papadopoulos E; Simopoulos C
Chirurgia (Bucur); 2005; 100(5):451-6. PubMed ID: 16372671
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex molecule expression in the human central nervous system: immunohistochemical analysis of 40 patients.
Sobel RA; Ames MB
J Neuropathol Exp Neurol; 1988 Jan; 47(1):19-28. PubMed ID: 3119782
[TBL] [Abstract][Full Text] [Related]
18. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
19. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognois.
Brunner CA; Gokel JM; Riethmüller ; Johnson JP
Eur J Cancer; 1991; 27(4):411-6. PubMed ID: 1828168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
